Johnson & Johnson said on Friday it discontinued a mid-stage study of its experimental drug to treat patients with moderate to severe atopic dermatitis after it failed to meet efficacy goals in an ...
The 15-day trial centers on Gayle Emerson, a Pennsylvania woman who claimed that her use of Johnson & Johnson's baby powder ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results